149490-75-5

Usage

Uses

Used in Cosmetic and Personal Care Industry:
Methyl 2-(3-hydroxyphenyl)-2-Methylpropanoate is used as a fragrance ingredient for its sweet, floral, and fruity scent. It is incorporated into perfumes, lotions, and other scented products to provide a desirable and pleasant aroma.
Used in Food Industry:
In the food industry, Methyl 2-(3-hydroxyphenyl)-2-Methylpropanoate is used as a flavoring agent to impart a sweet and fruity taste to certain food and beverage products. Its pleasant taste enhances the overall flavor profile of these products, making them more appealing to consumers.

Upstream product

• 268233-93-8 methyl 2-[3-(tert-butyldimethylsilanyloxy)phenyl]-2-methylpropionate 
• 70120-08-0 2-<3-(benzyloxy)phenyl>-2-methylpropionitrile 
• 628330-14-3 2-(3-benzyloxyphenyl)-2-methylpropanoic acid 
• 32454-33-4 methyl 2-(3-methoxyphenyl)-2-methylpropanoate 
• 628330-15-4 methyl 2-(3-benzyloxyphenyl)-2-methylpropanoate 

Downstream Products

• 946004-45-1 C₁₁H₁₃BrO₃ 
• 34356-75-7 3-(2-hydroxy-1,1-dimethylethyl)phenol 
• 1428900-30-4 2-{3-[3-(4-fluorophenoxy)-5-{[(4-hydroxy-4-isobutyl-1-piperidinyl)carbonyl]amino}phenoxy]phenyl}-2-methylpropanoic acid 
• 1257395-67-7 2-methyl-2-(6-(4-methyl-1-(4-(trifluoromethyl)piperidin-1-yl)pentyl)-4'-(trifluoromethyl)-[1,1'-biphenyl]-3-yl)propanoic acid 
• 1257395-48-4 2-{6-[(4-fluorophenyl)(4-methylpiperidin-1-yl)methyl]-4'-(trifluoromethyl)biphenyl-3-yl}-2-methylpropanoic acid 

Relevant academic research and scientific papers

CARBOXYLIC ACID-CONTAINING COMPOUNDS, DERIVATIVES THEREOF, AND RELATED METHODS OF USE

Compounds that modulate gamma secretase (e.g., alter the cleavage pattern of gamma secretase) are described herein. Also disclosed are pharmaceutical compositions, methods of modulating the activity of gamma secretase, and methods of treating Alzheimer's Disease using the compounds described herein.

COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families.

Biaryl cannabinoid mimetics-Synthesis and structure-activity relationship

Synthesis, in vitro biological evaluation, and structure-activity relationships of a biaryl cannabinoid mimetic 2 are reported. Variations in the substitution pattern yielded a number of agonists with low nanomolar affinity. Replacing the phenol group by

1,2-AZOLE DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY

A compound represented by the formula (1) wherein ring A is a ring optionally having 1 to 3 substituents; ring B is a 1,2-azole ring which may further have 1 to 3 substituents; Xa, Xb and Xc are the same or different and each is a bond, - O -, - S - and the like; Ya is a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; Yb and Yc are the same or different and each is a bond or a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; ring C is a monocyclic aromatic ring which may further have 1 to 3 substituents; and R represents -OR4 (R4 is hydrogen atom or optionally substituted hydrocarbon group) and the like, or a salt thereof or a prodrug thereof is useful as an agent for the prophylaxis or treatment of diabetes and the like.

Substituted benzopyran analogs for the treatment of inflammation

A class of benzopyrans, benzothiopyrans, dihydroquinolines, dihydronaphthalenes, and analogs thereof, is described for use in treating cyclooxygenase-2 mediated disorders. Compounds of particular interest are defined by Formula I'wherein X, A1, A2, A3, A4, R, R'', R1 and R2 are as described in the specification.